Compare Amgen, Inc. (AMGN) vs Logitech International SA (LOGI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amgen, Inc. vs Logitech International SA — how do they compare? Amgen, Inc. trades at $363.55 (market cap $196.12B), while Logitech International SA trades at $101.5 (market cap $14.65B). The key difference: Amgen, Inc. is far larger — about 13.4× Logitech International SA's market cap, and Amgen, Inc. pays the higher dividend (2.77%). Which is the better fit depends on your goals.
| AMGN | LOGI | |
|---|---|---|
Market Cap | $196.12B | $14.65B |
Sector | Health | Technology |
52-Week High | $388.16 | $126.69 |
52-Week Low | $271.18 | $85.84 |
Enterprise Value | $241.41B | $13.00B |
Dividend Yield | 2.77% | 1.67% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.
The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.
Logitech (LOGI) trades at $101.95, up 0.28% on the day, with a bullish technical signal despite mixed moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.13 exceeding the $1.10 estimate. Fundamentals show robust profitability, including a 43.2% gross margin and 32.78% ROE, while valuation ratios like P/E of 21.25 and P/S of 3.12 reflect moderate pricing. Recent news highlights partnerships, such as with Call of Duty: Modern Warfare 4, and product launches like the G3 Series, supporting growth momentum.
The outlook for LOGI is cautiously optimistic, with a consensus price target of $113.00 implying 11% upside. Opportunities include B2B expansion and AI-enabled products driving margin growth, but risks involve competitive pressures in peripherals and reliance on consumer spending. Analyst sentiment is divided, with 26% buy ratings balanced by equal sell recommendations, indicating uncertainty amid solid execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About Logitech International SA
Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →
